1. Home
  2. LESL vs CUE Comparison

LESL vs CUE Comparison

Compare LESL & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leslie's Inc.

LESL

Leslie's Inc.

HOLD

Current Price

$1.47

Market Cap

17.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$31.74

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LESL
CUE
Founded
1963
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
17.6M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
LESL
CUE
Price
$1.47
$31.74
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$2.54
$120.00
AVG Volume (30 Days)
133.1K
7.6M
Earning Date
05-18-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.11
EPS
N/A
N/A
Revenue
$1,241,915,000.00
$27,466,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
195.75
52 Week Low
$0.27
$0.17
52 Week High
$6.92
$41.42

Technical Indicators

Market Signals
Indicator
LESL
CUE
Relative Strength Index (RSI) 46.89 73.24
Support Level $0.90 $0.40
Resistance Level $1.60 N/A
Average True Range (ATR) 0.27 5.74
MACD -0.06 2.02
Stochastic Oscillator 12.38 74.86

Price Performance

Historical Comparison
LESL
CUE

About LESL Leslie's Inc.

Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products, including chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company serves residential pool, residential spa, professional pool, and commercial pool consumers and markets its products through over 1,000 company-operated locations in 39 states and e-commerce websites, operating only in the United States. It operates mainly in the pool and spa aftermarket industry and offers regularly purchased, non-discretionary maintenance items, along with installation and repair services for pool and spa equipment.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: